What is Hygeia Healthcare Holdings Co Ltd?
, Limited offers oncology healthcare services in the People's Republic of China.
HYHHF · Verdict
Solid reward · moderate risk
HYHHF stands out on growth and volatility, but watch the balance sheet signal.
Based on 88% data coverage
HYHHF · Verdict
Rev +24.3% CAGR · earnings +10.7%
Top decile vs peers
2% free-cash-flow margin
Current ratio 1.02
13% net margin · 7% ROE
Model-based scoring. For information only — not financial advice.
, Limited offers oncology healthcare services in the People's Republic of China. The company owns and operates private for-profit hospitals that offers oncology healthcare services, such as radiotherapy, chemotherapy, surgery, and targeted therapy, as well as cancer diagnosis, treatment, and rehabilitation. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 1.04B, and a P/E ratio of 16.8x.
The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.